Literature DB >> 20195239

Involvement of epimorphin in the repair of experimental renal fibrosis in mice.

Muneharu Yamada1, Takashi Oda, Keishi Higashi, Taketoshi Kushiyama, Kazuo Yamakami, Yutaka Sakurai, Yohei Hirai, Kojiro Yamamoto, Toshitake Hyodo, Shigenobu Suzuki, Soichiro Miura, Hiroo Kumagai.   

Abstract

Interaction between epithelial cells and mesenchymal cells is essential in normal organ morphogenesis and in tissue repair after injury. Epimorphin, a mesenchymal protein that regulates epithelial morphogenesis through epithelial-mesenchymal interactions, has recently attracted attention as an important modulator of tissue repair. In this study we analyzed the role of epimorphin in renal fibrosis. We first found a progressive increase in epimorphin expression corresponding to the progression of renal fibrosis in mice with unilateral ureteral obstruction (UUO). To determine whether this expression has a role in the repair or progression of renal fibrosis, we analyzed a model of renal fibrosis repair, the UUO-release (UUO-R) model. Epimorphin expression was increased at 3 and 7 days after the UUO-R rather than on the day of release, but was decreased at 21 days after the release. Inhibition of endogenous epimorphin with anti-epimorphin antibody (MC-1) significantly delayed the repair of fibrosis. When compared with normal-IgG-injected mice, MC-1-injected mice showed significantly decreased renal matrix metalloproteinase (MMP)-2 and MMP-9 expressions by western blotting and increased expression of TGF-beta and collagen-I mRNA by real-time RT-PCR. Recombinant epimorphin induced prominent increases in MMP-2 and MMP-9 activities in the culture media of renal interstitial fibroblasts in vitro. These findings indicate that epimorphin has a pivotal role in the repair of renal fibrosis by modulating both extracellular matrix (ECM) degradation and its production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195239     DOI: 10.1038/labinvest.2010.50

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Epimorphin expression in a rat model of pulmonary hypoplasia associated with congenital diaphragmatic hernia.

Authors:  İlke Akpinar; Dicle Korgun; Arzu Çetin; Akin Yesilkaya; Gungor Karaguzel; Cem Boneval; Mustafa Melikoglu
Journal:  Pediatr Surg Int       Date:  2014-08-15       Impact factor: 1.827

2.  Epimorphin deletion inhibits polyposis in the Apcmin/+ mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion.

Authors:  Elzbieta A Swietlicki; Shashi Bala; Jianyun Lu; Anisa Shaker; Gowri Kularatna; Marc S Levin; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

3.  Epimorphin(-/-) mice are protected, in part, from acute colitis via decreased interleukin 6 signaling.

Authors:  Anisa Shaker; Matthew Gargus; Julie Fink; Jana Binkley; Isra Darwech; Elzbieta Swietlicki; Marc S Levin; Deborah C Rubin
Journal:  Transl Res       Date:  2014-03-25       Impact factor: 7.012

4.  Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis.

Authors:  Takahiro Uchida; Takashi Oda; Hidehito Matsubara; Atsushi Watanabe; Hanako Takechi; Naoki Oshima; Yutaka Sakurai; Hiroo Kumagai
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

5.  Clinical and immunological implications of increase in CD208+ dendritic cells in tonsils of patients with immunoglobulin A nephropathy.

Authors:  Hanako Takechi; Takashi Oda; Osamu Hotta; Kojiro Yamamoto; Naoki Oshima; Takeshi Matsunobu; Akihiro Shiotani; Hiroshi Nagura; Hideyuki Shimazaki; Seiichi Tamai; Yutaka Sakurai; Hiroo Kumagai
Journal:  Nephrol Dial Transplant       Date:  2013-09-29       Impact factor: 5.992

6.  Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.

Authors:  James Pritchett; Varinder S Athwal; Emma Harvey; Katherine Martin; Jessica Llewellyn; Philip Ireland; Alexander Nicolaides; Martin J Humphries; Nicoletta Bobola; Neil A Hanley; Karen Piper Hanley
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.